1,207
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

Design, synthesis, and evaluation of 1, 4-benzodioxan-substituted chalcones as selective and reversible inhibitors of human monoamine oxidase B

, , &
Pages 1513-1523 | Received 17 May 2020, Accepted 14 Jul 2020, Published online: 23 Jul 2020

References

  • Volz H-P, Gleiter CH. Monoamine oxidase inhibitors. A perspective on their use in the elderly. Drugs Aging 1998;13:341–55.
  • Garrick NA, Murphy DL. Monoamine oxidase type a: differences in selectivity towards l-norepinephrine compared to serotonin. Biochem Pharmacol 1982;31:4061–6.
  • Gaspar A, Silva T, Yáñez M, et al. Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors. J Med Chem 2011;54:5165–73.
  • Bortolato M, Chen K, Shih JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev 2008;60:1527–33.
  • Saura J, Luque JM, Cesura AM, et al. Increased monoamine oxidase b activity in plaque-associated astrocytes of alzheimer brains revealed by quantitative enzyme radioautography. Neuroscience 1994;62:15–30.
  • Tripathi AC, Upadhyay S, Paliwal S, Saraf SK. Privileged scaffolds as mao inhibitors: retrospect and prospects. Eur J Med Chem 2018;145:445–97.
  • Meleddu R, Distinto S, Cirilli R, et al. Through scaffold modification to 3,5-diaryl-4,5-dihydroisoxazoles: new potent and selective inhibitors of monoamine oxidase b. J Enzyme Inhib Med Chem 2017;32:264–70.
  • Matos MJ, Vilar S, Gonzalez-Franco RM, et al. Novel (coumarin-3-yl)carbamates as selective mao-b inhibitors: synthesis, in vitro and in vivo assays, theoretical evaluation of adme properties and docking study. Eur J Med Chem 2013;63:151–61.
  • De Colibus L, Li M, Binda C, et al. Three-dimensional structure of human monoamine oxidase a (mao a): relation to the structures of rat mao a and human mao b. Proc. Natl. Acad. Sci. USA 2005;102:12684–9.
  • Carradori S, Silvestri R. New frontiers in selective human mao-b inhibitors. J Med Chem 2015;58:6717–32.
  • Reis J, Cagide F, Chavarria D, et al. Discovery of new chemical entities for old targets: insights on the lead optimization of chromone-based monoamine oxidase b (mao-b) inhibitors. J Med Chem 2016;59:5879–93.
  • Chimenti F, Fioravanti R, Bolasco A, et al. Chalcones: a valid scaffold for monoamine oxidases inhibitors. J Med Chem 2009;52:2818–24.
  • Minders C, Petzer JP, Petzer A, Lourens A. Monoamine oxidase inhibitory activities of heterocyclic chalcones. Bioorg Med Chem Lett 2015;25:5270–6.
  • Jo G, Ahn S, Kim B-G, et al. Chromenylchalcones with inhibitory effects on monoamine oxidase b. Bioorg Med Chem 2013;21:7890–7.
  • Zaib S, Umar Farooq Rizvi S, Aslam S, et al. Quinolinyl-thienyl chalcones as monoamine oxidase inhibitors and their in silico modeling studies. Med Chem 2015;11:580–9.
  • Sasidharan R, Manju SL, Uçar G, et al. Identification of indole-based chalcones: discovery of a potent, selective, and reversible class of mao-b inhibitors. Arch. Pharm. 2016;349:627–37.
  • Engelbrecht I, Petzer JP, Petzer A. The synthesis and evaluation of sesamol and benzodioxane derivatives as inhibitors of monoamine oxidase. Bioorg Med Chem Lett 2015;25:1896–900.
  • Lu C, Guo Y, Yan J, et al. Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer’s disease. J Med Chem 2013;56:5843–59.
  • Binda C, Wang J, Pisani L, et al. Structures of human monoamine oxidase b complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 2007;50:5848–52.
  • Son S-Y, Ma J, Kondou Y, et al. Structure of human monoamine oxidase a at 2.2- resolution: the control of opening the entry for substrates/inhibitors. Proc Natl Acad Sci 2008;105:5739–44.
  • Distinto S, Yáñez M, Alcaro S, et al. Synthesis and biological assessment of novel 2-thiazolylhydrazones and computational analysis of their recognition by monoamine oxidase b. Eur J Med Chem 2012;48:284–95.
  • Zhuo K, de-meng S, ai-qian C, Yun H. Synthesis and monoamine oxidase b inhibitory activities of isoquiritigenin derivatives. China J Chin Mater Med 2019;44:4653–60.
  • Hammuda A, Shalaby R, Rovida S, et al. Design and synthesis of novel chalcones as potent selective monoamine oxidase-b inhibitors. Eur J Med Chem 2016;114:162–9.
  • Reis J, Manzella N, Cagide F, et al. Tight-binding inhibition of human monoamine oxidase b by chromone analogs: a kinetic, crystallographic, and biological analysis. J Med Chem 2018;61:4203–12.
  • Sirimulla S, Bailey JB, Vegesna R, Narayan M. Halogen interactions in protein-ligand complexes: implications of halogen bonding for rational drug design. J Chem Inf Model 2013;53:2781–91.
  • Tzvetkov NT, Stammler H-G, Georgieva MG, et al. Carboxamides vs. methanimines: crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl) methanimines as monoamine oxidase b and acetylcholinesterase inhibitors. Eur J Med Chem 2019;179:404–22.
  • Clark DE. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 2. Prediction of blood-brain barrier penetration. J Pharm Sci 1999;88:815–21.
  • Liu H, Wang L, Lv M, et al. Alzplatform: an Alzheimer’s disease domain-specific chemogenomics knowledgebase for polypharmacology and target identification research. J Chem Inf Model 2014;54:1050–60.